Advanced oxidation protein products, parathyroid hormone and vascular calcification in uremia

被引:18
作者
Drüeke, TB [1 ]
Massy, ZA [1 ]
机构
[1] Hop Necker Enfants Malad, INSERM, U507, F-75743 Paris 15, France
关键词
vascular calcification; uremia; oxidative stress; advanced oxidation protein products; parathyroid hormone;
D O I
10.1159/000065203
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vascular calcification is a frequent complication of uremic patients. In addition to classical risk factors such as age, male gender, smoking, inflammation, hypertension, dyslipidemia, and diabetes, which also exist in the general population, patients with chronic renal failure have other risk factors such as oxidative stress, inflammation, hyperparathyroidism, hypoparathyroidism, hypercalcemia, hyperphosphatemia, and overtreatment with calcium and vitamin D. These latter risk factors may even have a better predictive value than classical risk factors for coronary heart disease in uremic patients. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:494 / 497
页数:4
相关论文
共 30 条
[1]   Hypochlorite modification of high density lipoprotein: effects on cholesterol efflux from J774 macrophages [J].
Bergt, C ;
Reicher, H ;
Malle, E ;
Sattler, W .
FEBS LETTERS, 1999, 452 (03) :295-300
[2]   osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification [J].
Bucay, N ;
Sarosi, I ;
Dunstan, CR ;
Morony, S ;
Tarpley, J ;
Capparelli, C ;
Scully, S ;
Tan, HL ;
Xu, WL ;
Lacey, DL ;
Boyle, WJ ;
Simonet, WS .
GENES & DEVELOPMENT, 1998, 12 (09) :1260-1268
[3]   Morphological predictors of arterial remodeling in coronary atherosclerosis [J].
Burke, AP ;
Kolodgie, FD ;
Farb, A ;
Weber, D ;
Virmani, R .
CIRCULATION, 2002, 105 (03) :297-303
[4]   Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients [J].
Cheung, AK ;
Sarnak, MJ ;
Yan, GF ;
Dwyer, JT ;
Heyka, RJ ;
Rocco, MV ;
Teehan, BP ;
Levey, AS .
KIDNEY INTERNATIONAL, 2000, 58 (01) :353-362
[5]  
Drueke T B, 2000, Adv Nephrol Necker Hosp, V30, P333
[6]   Medical management of secondary hyperparathyroidism in uremia [J].
Drüeke, TB .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1999, 317 (06) :383-389
[7]  
DRUEKE TB, 2002, IN PRESS CIRCULATION
[8]   Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis [J].
Goodman, WG ;
Goldin, J ;
Kuizon, BD ;
Yoon, C ;
Gales, B ;
Sider, D ;
Wang, Y ;
Chung, J ;
Emerick, A ;
Greaser, L ;
Elashoff, RM ;
Salusky, IB .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (20) :1478-1483
[9]   Arterial stiffening and vascular calcifications in end-stage renal disease [J].
Guérin, AP ;
London, GM ;
Marchais, SJ ;
Metivier, F .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (07) :1014-1021
[10]   Elevated plasma F2-isoprostanes in patients on long-term hemodialysis [J].
Handelman, GJ ;
Walter, MF ;
Adhikarla, R ;
Gross, J ;
Dallal, GE ;
Levin, NW ;
Blumberg, JB .
KIDNEY INTERNATIONAL, 2001, 59 (05) :1960-1966